First Time Loading...

Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 30.83 USD 1.85% Market Closed
Updated: May 6, 2024

Supernus Pharmaceuticals Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Supernus Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Cash from Investing Activities
$268.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Investing Activities
-$2.9B
CAGR 3-Years
48%
CAGR 5-Years
5%
CAGR 10-Years
7%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Investing Activities
-$21.7B
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash from Investing Activities
-$32.3B
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Investing Activities
-$14.1B
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Eli Lilly and Co
NYSE:LLY
Cash from Investing Activities
-$7.6B
CAGR 3-Years
-45%
CAGR 5-Years
-6%
CAGR 10-Years
-10%

See Also

What is Supernus Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
268.7m USD

Based on the financial report for Dec 31, 2023, Supernus Pharmaceuticals Inc's Cash from Investing Activities amounts to 268.7m USD.